Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (<i>EGFR</i>) Mutation with a History of Acquired Resistance to Osimertinib
Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (<i>EGFR</i>) Mutation with a History of Acquired Resistance to Osimertinib
复制标题
奥希替尼重新给药对具有表皮生长因子受体 (<i>EGFR</i>) 突变且有奥希替尼获得性耐药史的非小细胞肺癌的有益效果
DOI：
10.2169/internalmedicine.2152-18
复制
发表时间：
2019
影响因子：
1.2
通讯作者：
Kiura K
中科院分区：
文献类型：
--
作者：
Makimoto G;Ohashi K;Senoo S;Hotta K;Maeda Y;Kiura K
